Saturday 17 October 2026 Export CERT’s income statement to Excel — free account

Certara, Inc.

CERT Healthcare Health Information Services

In the quarter to June 2026, revenue was flat, EPS fell 3,500.0%, free cash flow fell 78.5% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

9.37 0.29 −3.00%

Follow CERT

Alert me

Market cap: $1.5B
P/E: 0.0×
Fwd P/E: −58.4×
Dividend yield: —
F-score: 6/9
Altman Z: 2.04
Beneish M: −2.77
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.20

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	1	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 37.08%

Capital & Financial Ratios $m

Market Cap 1,470.00

Revenue 420.66

Net Income (22.50)

Free Cash Flow 54.57

Net Debt 107.70

Current Ratio 2.55

Debt/Equity 0.30

P/E ratio 0.00

Fwd P/E (58.40)

P/S ratio 3.44

P/B ratio 1.50

Past 5Y EPS Growth —

This Y EPS Growth (22.70%)

Next Y EPS Growth 16.71%

Next Y revenue growth (9.61%)

Next 5Y EPS Growth 0.20%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 13.06%

10-year low 10-year high

P/B against its own 10 years 16.62%

10-year low 10-year high

EV/Sales against its own 10 years 12.78%

10-year low 10-year high

EV/FCF against its own 10 years 26.63%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	235	179	189	184
Receivables	85	102	104	101
Inventory	—	—	—	—
Other	—	—	—	—
	340	311	315	312

	2023	2024	2025	Q'26
Payables	5	4	3	3
ST’ Debt	3	3	3	3
Other	4	5	4	3
	130	146	153	122

Compound Annual Growth %

	10y	5y	3y
Sales	—	11.45%	7.66%
Cash Flow	—	16.54%	1.34%
Earnings	—	0.00%	0.00%
Book Value	—	5.27%	(0.52%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	107	93	—	—	—
’25	106	92	105	116	419
’24	97	93	95	100	385
’23	90	90	86	88	354
’22	82	83	85	87	336
’21	67	70	74	75	286
’20	57	61	60	65	244

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	12	10	—	—	—
’25	17	18	32	29	96
’24	4	10	17	49	80
’23	10	18	31	23	83
’22	10	23	24	35	93
’21	5	15	20	21	60
’20	9	8	15	13	45

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	5	2	—	—	—
’25	12	11	26	22	70
’24	1	4	11	44	59
’23	7	14	27	19	67
’22	7	20	21	32	80
’21	4	12	17	18	51
’20	6	6	14	11	37

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.06)	(0.36)	—	—	—
’25	0.03	(0.01)	0.01	(0.04)	(0.01)
’24	(0.03)	(0.08)	(0.01)	0.04	(0.08)
’23	0.01	0.03	(0.31)	(0.08)	(0.35)
’22	0.01	0.00	0.02	0.06	0.09
’21	0.01	(0.02)	(0.01)	(0.06)	(0.09)
’20	0.01	0.02	0.01	(0.40)	(0.37)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	—	29.70	23.75	10.60	11.81	9.41	8.03	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	—	41.79	45.48	29.04	24.96	19.87	15.69
People
People	Employees	—	—	—	899	903	1,114	1,204	1,391	1,546	1,576
	Revenue/emp, $m	—	—	0.00	0.23	0.27	0.26	0.28	0.25	0.25	0.27
Income, $m
Income, $m	Revenue	—	—	164	209	244	286	336	354	385	419
	Gross margin, %	—	—	56.61	61.74	58.62	60.99	60.50	60.20	59.88	61.53
	EBT	—	—	(33)	(9)	(50)	(3)	19	(55)	(17)	8
	EBT margin, %	—	—	(19.89)	(4.39)	(20.61)	(1.18)	5.59	(15.56)	(4.46)	1.82
	Net income	—	0	(33)	(9)	(49)	(13)	15	(55)	(12)	(2)
	Depreciation	—	—	39	43	44	47	54	105	69	76
Per share, $
Per share, $	Revenue	—	—	1.24	1.57	1.83	1.91	2.14	2.23	2.40	2.61
	Earnings	—	—	(0.25)	(0.07)	(0.37)	(0.09)	0.09	(0.35)	(0.08)	(0.01)
	Cash flow	—	—	0.09	0.29	0.34	0.40	0.59	0.52	0.50	0.60
	Capex	—	—	(0.09)	(0.07)	(0.06)	(0.06)	(0.08)	(0.10)	(0.13)	(0.17)
	Free cash flow	—	—	0.00	0.22	0.28	0.34	0.51	0.42	0.37	0.44
	Book value	—	—	3.72	3.72	6.17	6.95	6.88	6.59	6.60	6.63
	Shares, m	—	—	132	132	133	150	157	159	160	160
Valuation, ×
Valuation, ×	P/E	—	—	0.00	0.00	0.00	0.00	161.75	0.00	0.00	0.00
	P/S	—	—	0.00	0.00	18.45	14.88	7.59	7.78	4.44	3.37
	P/B	—	—	10.13	10.13	5.47	4.09	2.36	2.63	1.61	1.33
	EV/Sales	—	—	0.00	0.00	18.55	15.26	7.75	7.94	4.74	3.62
	EV/FCF	—	—	119.28	119.28	122.54	84.81	32.51	41.69	30.70	21.74
Cash, $m
Cash, $m	Operating cash flow	—	—	12	38	45	60	93	83	80	96
	Capex	—	—	(11)	(10)	(8)	(9)	(13)	(15)	(21)	(27)
	Free cash flow	—	—	0	29	37	51	80	67	59	70
Balance, $m
Balance, $m	Working capital	—	—	3	25	271	183	239	210	165	162
	Total debt	—	—	408	401	299	295	293	291	295	293
	Net debt	—	—	396	372	25	108	53	56	116	104
	Shareholders’ equity	—	—	493	492	822	1,042	1,080	1,047	1,059	1,063
Returns, %
Returns, %	ROA	—	—	(6.33)	(0.85)	(4.28)	(0.95)	0.96	(3.53)	(0.77)	(0.10)
	ROIC	—	—	(0.33)	1.42	(1.80)	0.74	1.79	(2.31)	(0.09)	1.13
	ROE	—	—	(6.75)	(1.81)	(7.52)	(1.42)	1.39	(5.21)	(1.14)	(0.15)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
PRVA Privia Health Group, Inc.	$2.9B	102×	87.8×	+21.39% (above 0%: growing)	+250.00% (above 0%: growing)	−86.20% (below 0%: shrinking)	9.93%	1.86%	Compare
SDGR Schrodinger, Inc.	$1.9B	— (loss-making)	— (loss-making)	+7.54% (above 0%: growing)	n/m	+34.43% (above 0%: growing)	55.07%	(70.55%)	Compare
OMCL Omnicell, Inc.	$1.6B	41.6×	55.1×	+7.45% (above 0%: growing)	+341.67% (above 0%: growing)	+107.90% (above 0%: growing)	48.98%	10.39%	Compare
CERT Certara, Inc.	$1.5B	— (loss-making)	— (loss-making)	+0.99% (above 0%: growing)	n/m	−78.46% (below 0%: shrinking)	62.34%	(0.21%)
GDRX GoodRx Holdings, Inc.	$1.2B	62.7×	30.9×	−1.31% (below 0%: shrinking)	−25.00% (below 0%: shrinking)	+112.45% (above 0%: growing)	89.52%	11.79%	Compare
OMDA Omada Health, Inc.	$1.1B	252×	143×	+43.12% (above 0%: growing)	n/m	+45.71% (above 0%: growing)	72.62%	4.04%	Compare
TDOC Teladoc Health, Inc.	$1.1B	— (loss-making)	— (loss-making)	−3.95% (below 0%: shrinking)	n/m	−27.07% (below 0%: shrinking)	68.56%	(6.11%)	Compare
HSTM HealthStream, Inc.	$1.0B	46.0×	34.4×	+12.55% (above 0%: growing)	+27.78% (above 0%: growing)	+362.71% (above 0%: growing)	65.35%	9.94%	Compare
PHR Phreesia, Inc.	$685.3M	64.4×	23.5×	+10.41% (above 0%: growing)	+200.00% (above 0%: growing)	+43.51% (above 0%: growing)	66.64%	5.88%	Compare
Median of peers	$1.2B	63.5×	44.8×	+8.98%	+200.00%	+44.61%	66.00%	4.96%

All 51 Health Information Services stocks →

Certara, Inc. (CERT) key facts

Certara, Inc. (CERT) is a Health Information Services company in the Healthcare sector, listed on Nasdaq.
As of October 16, 2026, CERT traded at $9.37, a market capitalization of $1.5 billion.
Return on equity was −0.15% and debt-to-equity 0.30.
Its Piotroski F-score is 6 out of 9 and its Altman Z-score is 2.04 (grey zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.